Hilar cholangiocarcinoma (hCCA) is a primary liver tumor associated with a dim prognosis.
The role of preoperative and palliative biliary drainage has long been debated. The most …

Abstract Biliary drainage for Perihilar Cholangiocarcinoma (PCCA) can be performed either
by endoscopic retrograde cholangiopancreatography or Percutaneous Transhepatic Biliary …

Although Spy DS (SpyGlass DS Direct Visualization System) is considered to be useful for
the diagnosis of bile duct strictures and the treatment of bile duct stones, there is limited data …

Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second leading
cause of cancer-related death by 2030, with approximately 50% of patients having …

Background and aims Relief of cholestasis in hilar cholangiocarcinoma is commonly
undertaken in both curative and palliative treatment plans. There are numerous open …

Purpose: To compare the results of surgical treatment and changes in biomarkers of
cholestasis, endotoxicosis, cytolysis, lipid peroxidation, glycolysis disorders, and …

Background Both radiofrequency ablation (RFA), photodynamic therapy (PDT), and biliary
stent alone are common local palliative therapies for unresectable malignant biliary …

Pancreatic adenocarcinoma is a lethal disease with a mortality rate that has not significantly
improved over decades. This is likely due to several challenges unique to pancreatic cancer …

Obstructive jaundice (OJ) is a common problem in daily clinical practice. However,
completely understanding the pathophysiological changes in OJ remains a challenge for …

Pancreatic cancer (PC) is an intricate malignancy with poor prognosis. In the present state of
the art review paper and clinical trial trend analysis, we explore the current clinically …